Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Hyperfine, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of HYPR: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders3436+2
Shares9.24M9.17M−67.9K (−0.7%)
Value$13.2M$19.7M+$6.56M (+49.8%)

New holders (5)

Institutions that held Hyperfine, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to HYPR in Q2 2023
InstitutionSharesValue% of portfolio
EAM Investors, LLC541,065$1.16M0.22%
Cresset Asset Management, LLC11,500$24.7K0.00%
Morgan Stanley7,000$15.1K0.00%
Rhumbline Advisers4,588$9.86K0.00%
Hoey Investments, Inc1,000$2.15K0.00%

Sold out (3)

Institutions that held Hyperfine, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of HYPR in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Security Benefit Life Insurance Co777,143$1.12M
Nantahala Capital Management, LLC368,417$530.5K
EP Wealth Advisors, LLC100,000$10